KELLY HOLMES: Open Payments
NPI 1952317281 · CLINTON TWP, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$750 in 27 payments from 12 companies in 2025. Trend: 2023 $738 · 2024 $571 · 2025 $750
Food & beverage: $665Education: $85
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 4 | $160 |
| Regeneron Healthcare Solutions, Inc. | 2 | $120 |
| ABBVIE INC. | 5 | $100 |
| Incyte Corporation | 4 | $92 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| Amgen Inc. | 2 | $55 |
| Janssen Biotech, Inc. | 1 | $33 |
| Organon LLC | 1 | $29 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
Products named: Bimzelx, DUPIXENT, OPZELURA, COSENTYX, SKYRIZI, OTEZLA, TREMFYA, RINVOQ.
Industry payments across MI — which companies pay providers there.
